Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Thromboembolic events in patients with advanced stage non-small cell lung cancer treated with platinum-based chemotherapy: a prospective observational study.

Joshi A, Kate S, Noronha V, Patil V, Trivedi V, Goud S, More S, Bhairva S, Prabhash K.

Ecancermedicalscience. 2018 Oct 9;12:876. doi: 10.3332/ecancer.2018.876. eCollection 2018.

2.

Retrospective evaluation of thromboembolic events in patients with non-small cell lung cancer treated with platinum-based chemotherapy.

Mellema WW, van der Hoek D, Postmus PE, Smit EF.

Lung Cancer. 2014 Oct;86(1):73-7. doi: 10.1016/j.lungcan.2014.07.017. Epub 2014 Aug 2.

PMID:
25129368
3.

Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group.

Starling N, Rao S, Cunningham D, Iveson T, Nicolson M, Coxon F, Middleton G, Daniel F, Oates J, Norman AR.

J Clin Oncol. 2009 Aug 10;27(23):3786-93. doi: 10.1200/JCO.2008.19.4274. Epub 2009 Apr 27.

PMID:
19398575
4.

Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study.

Barni S, Labianca R, Agnelli G, Bonizzoni E, Verso M, Mandalà M, Brighenti M, Petrelli F, Bianchini C, Perrone T, Gasparini G.

J Transl Med. 2011 Oct 20;9:179. doi: 10.1186/1479-5876-9-179.

5.

Predictors of thrombosis in testicular cancer during platinum-based chemotherapy.

Paffenholz P, Grein K, Heidegger I, Nestler T, Grabbert M, Salem J, Hellmich M, Pfister D, Heidenreich A.

World J Urol. 2018 Dec 13. doi: 10.1007/s00345-018-2598-7. [Epub ahead of print]

PMID:
30547197
6.

Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer.

Lee YG, Lee E, Kim I, Lee KW, Kim TM, Lee SH, Kim DW, Heo DS.

Cancer Res Treat. 2015 Oct;47(4):670-5. doi: 10.4143/crt.2014.045. Epub 2015 Jan 2.

7.

Patients treated with platinum-doublet chemotherapy for advanced non--small-cell lung cancer have inferior outcomes if previously treated with platinum-based chemoradiation.

Paramanathan A, Solomon B, Collins M, Franco M, Kofoed S, Francis H, Ball D, Mileshkin L.

Clin Lung Cancer. 2013 Sep;14(5):508-12. doi: 10.1016/j.cllc.2013.03.007. Epub 2013 Jun 20.

PMID:
23792009
8.

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.

Scappaticci FA, Skillings JR, Holden SN, Gerber HP, Miller K, Kabbinavar F, Bergsland E, Ngai J, Holmgren E, Wang J, Hurwitz H.

J Natl Cancer Inst. 2007 Aug 15;99(16):1232-9. Epub 2007 Aug 8. Erratum in: J Natl Cancer Inst. 2008 Jan 16;100(2):156. J Natl Cancer Inst. 2008 May 7;100(9):685.

PMID:
17686822
9.

[Frequency of thromboembolic complications in patients with lung cancer].

Crolow C, Samulowski M, Blum T, Kollmeier J, Schönfeld N, Bittner RC, Behr J, Bauer TT, Grüning W.

Pneumologie. 2013 Aug;67(8):442-7. doi: 10.1055/s-0033-1344341. Epub 2013 Jul 8. German.

10.
11.

The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents.

Tully CM, Apolo AB, Zabor EC, Regazzi AM, Ostrovnaya I, Furberg HF, Rosenberg JE, Bajorin DF.

Cancer. 2016 Mar 1;122(5):712-21. doi: 10.1002/cncr.29801. Epub 2015 Nov 30.

13.

Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer.

Epstein AS, Soff GA, Capanu M, Crosbie C, Shah MA, Kelsen DP, Denton B, Gardos S, O'Reilly EM.

Cancer. 2012 Jun 15;118(12):3053-61. doi: 10.1002/cncr.26600. Epub 2011 Oct 11.

14.

Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look!

Abdel-Razeq H, Mansour A, Abdulelah H, Al-Shwayat A, Makoseh M, Ibrahim M, Abunasser M, Rimawi D, Al-Rabaiah A, Alfar R, Abufara A, Ibrahim A, Bawaliz A, Ismael Y.

Thromb J. 2018 Mar 1;16:2. doi: 10.1186/s12959-018-0161-9. eCollection 2018.

15.
16.

Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients.

Kashuk JL, Moore EE, Sabel A, Barnett C, Haenel J, Le T, Pezold M, Lawrence J, Biffl WL, Cothren CC, Johnson JL.

Surgery. 2009 Oct;146(4):764-72; discussion 772-4. doi: 10.1016/j.surg.2009.06.054.

PMID:
19789037
17.

The incidence of thromboembolic events in surgically treated ankle fracture.

Pelet S, Roger ME, Belzile EL, Bouchard M.

J Bone Joint Surg Am. 2012 Mar 21;94(6):502-6. doi: 10.2106/JBJS.J.01190.

PMID:
22437998
18.

A systematic overview of chemotherapy effects in ovarian cancer.

Högberg T, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):340-60. Review.

PMID:
11441940
19.
20.

Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.

Kim SH, Lee GW, Lee MJ, Cho YJ, Jeong YY, Kim HC, Lee JD, Hwang YS, Kim IS, Lee S, Oh SY.

Lung Cancer. 2012 Sep;77(3):578-84. doi: 10.1016/j.lungcan.2012.04.016. Epub 2012 May 18.

PMID:
22608006

Supplemental Content

Support Center